Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines

Kensuke Naito, Akihiro Takeshita, Kohichiro Shigeno, Shota Nakamura, Shinya Fujisawa, Kaori Shinjo, Hiromu Yoshida, Kazunori Ohnishi, M. MORI, S. Terakawa,

Leukemia · 2000 · 152 citations · 33 references

Concepts

References

33